Search the Newsreel

What Maplebear (CART)'s First UK Caper Smart Trolley Partnership with Morrisons Means For Shareholders

In late July 2026, Instacart and Morrisons introduced AI-powered Caper smart trolleys at Morrisons' Preston supermarket, Instacart's first UK retail partnership for this technology, enabling automatic item recognition, on-the-spot produce weighing, budget tracking, loyalty integration, and faster checkout through dedicated Caper lanes. The rollout …

Maplebear (CART) Launches UK Smart Trolleys As Fair Value Narrative Stays In Focus

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Instacart parent Maplebear (CART) is drawing attention after launching its AI-powered Caper smart trolleys with UK grocer Morrisons, the company's first British retail partnership for …

Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview

Cartesian Therapeutics Inc is anticipated to report a loss of 87 cents per share. This earnings preview is based on information from Refinitiv and was published by Reuters. The full article can be accessed on TradingView for subscribers.

Carter's Q2 Earnings Beat Estimates on Wholesale and Retail Gains

Carter's, Inc. (CRI) reported strong second-quarter 2026 results, surpassing earnings and revenue estimates driven by gains across its U.S. Retail and Wholesale segments. Despite a contraction in adjusted gross margin due to tariff costs, the company saw increased adjusted operating income and maintained a …

Carter's (CRI) Stock Profit Beat Meets Lingering Margin Pressure

Carter's net sales up 5 percent in Q2 2026, exceeds prior outlook

Carter's, a US kidswear company, announced its Q2 2026 financial results, showing a 5.2 percent increase in net sales to $615.50 million and a significant rise in operating income to $139.80 million, exceeding prior expectations. This growth was attributed to a recovery of import …

ETFs Investing in Maplebear Inc. Stocks

This article lists various ETFs that hold Maplebear Inc. stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return for each fund. The purpose is to help investors find …

Carter Bankshares, Inc. (NASDAQ:CARE) Given Consensus Recommendation of "Hold" by Analysts

Carter Bankshares, Inc. (NASDAQ:CARE) has received a consensus "Hold" rating from analysts, with an average 12-month target price of $30.75. Recent analyst actions include downgrades from Freedom Capital and Raymond James, and upgrades from Wall Street Zen and Weiss Ratings. The company recently announced …

Empowered Funds LLC Acquires New Shares in Carter's, Inc. $CRI

Empowered Funds LLC has acquired 136,908 shares of Carter's, Inc. (NYSE:CRI) during the first quarter, valuing their new position at approximately $4.9 million. This acquisition comes as Carter's reported strong second-quarter earnings, beating analyst estimates, but issued third-quarter revenue guidance below expectations. Analysts currently …

Carter's, Inc. $CRI Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Carter's, Inc. (NYSE:CRI) by 36.6% in the first quarter, now owning 4.79% of the company. This comes as Carter's reported strong second-quarter earnings, beating analyst estimates for both EPS and revenue, though third-quarter revenue guidance …

Descartes Systems Group (TSX:DSG) Wins AI Logistics Client As Its Valuation Case Stays In Focus

Did Strong Q2 Results and Tariff Windfall Just Shift Carter’s (CRI) Investment Narrative?

Carter's, Inc. reported past second-quarter 2026 results with net sales rising to US$615.49 million and net income jumping to US$104.96 million, alongside a tariff recovery that left it holding more than US$650 million in cash. Despite tightening its full-year outlook to a modest 2%–3% …

Is Carter's (CRI) Undervalued On Its Earnings Update And New Guidance?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Carter's (CRI) is back in focus after reporting its second quarter and first half 2026 results, alongside fresh guidance for the rest of …

The Descartes Systems Group Inc. $DSGX Shares Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC increased its stake in The Descartes Systems Group Inc. (NASDAQ:DSGX) by 10.2% in the first quarter, acquiring an additional 45,558 shares. This brings their total holdings to 490,898 shares valued at approximately $35.1 million. The company's stock has a …

Argent Capital Management LLC Buys 32,824 Shares of The Descartes Systems Group Inc. $DSGX

Argent Capital Management LLC significantly increased its stake in The Descartes Systems Group Inc. (NASDAQ:DSGX) by 56.9% in the first quarter, purchasing an additional 32,824 shares to bring its total holding to 90,549 shares valued at approximately $6.48 million. Institutional investors now collectively own …

Price to sales forward of Cartesian Therapeutics, Inc. – NASDAQ:RNAC

This article focuses on the "Price to sales forward" financial metric for Cartesian Therapeutics, Inc. (NASDAQ: RNAC). It appears to be a financial data page from TradingView, providing an overview of the company's stock information and financial figures.

CARTERS INC 2026: Revenue $615.49M, EPS $2.87— 10-Q Summary

CARTERS INC (CRI) reported strong financial results for the quarter ended 2026, with revenue reaching $615.49M and diluted EPS of $2.87. This growth was attributed to increased average unit retail and volume across all channels, leading to a significant rise in net income to …

Enterprise value of Descartes Systems Group Inc. – HAM:DC2

This article focuses on the enterprise value of Descartes Systems Group Inc. (HAM:DC2) as presented on TradingView. It provides market information and financial data for the company on the Hamburg Stock Exchange. The content is primarily a data placeholder within a financial platform, showing …

Carter's Flags Consumer Pricing Resistance, Moderates Back-Half Outlook Despite Strong Q2

Carter's reported a strong second quarter with a fifth consecutive quarter of comparable sales growth and a $100 million tariff refund. However, the company noted increasing consumer resistance to pricing and a loss of unit velocity, leading to a moderated outlook for the second …

Carter's Q2 Earnings Call Highlights

Key Points Interested in Carter's, Inc.? Here are five stocks we like better. Carter's exceeded its Q2 outlook: Net sales rose 5% to $615 million, while adjusted operating income increased 54% to $18 million and adjusted EPS climbed 53% to $0.26. Results benefited from …

Carter's, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:CRI) 2026-07-31

Carter's, Inc. (NYSE:CRI) has released its Q2 2026 earnings call presentation, reporting an EPS of $0.26, beating estimates by $0.20, and revenue of $615.49 million, surpassing expectations by $9.35 million with a 5.16% year-over-year increase. This article provides access to the slide deck published …

Vanguard Capital Management (CARE) discloses 1.1M-share Carter Bankshares position

Vanguard Capital Management LLC has disclosed beneficial ownership of 1,101,459 shares of Carter Bankshares Inc common stock, representing 4.95% of the class, through an amended Schedule 13G filing. Vanguard holds sole voting power over 145,582 shares and sole dispositive power over all 1,101,459 shares. …

Deutsche Bank Adjusts Maplebear Price Target to $45 From $41, Maintains Hold Rating

Deutsche Bank has adjusted its price target for Maplebear (Instacart) to $45, an increase from its previous target of $41. Despite this upward revision, the bank has maintained its "Hold" rating on the company's stock. This news was released on July 31, 2026, at …

Carter's (CRI) Beats Q2 Earnings and Revenue Estimates

Carter's (CRI) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Carter's Non-GAAP EPS of $0.26 beats by $0.20, revenue of $615M beats by $8.86M

* Carter's press release [https://seekingalpha.com/pr/20602627-carter-s-inc-reports-second-quarter-fiscal-2026-results] (CRI [https://seekingalpha.com/symbol/CRI]): Q2 Non-GAAP EPS of $0.26 beats by $0.20. * Revenue of $615M (+5.1% Y/Y) beats by $8.86M. * U.S. Retail comparable sales increased 5.1% * For fiscal year 2026 (a 52 week fiscal year), the Company projects …

The Descartes Systems Group Inc. $DSGX Shares Purchased by Janus Henderson Group PLC

Janus Henderson Group PLC increased its stake in The Descartes Systems Group Inc. by 4.1%, acquiring 100,937 additional shares and bringing its total holdings to 2.57 million shares valued at approximately $184.1 million. The Descartes Systems Group reported quarterly EPS of $0.55, surpassing consensus …

RNAC|Cartesian Therapeutics Inc|Price:7.800|Chg%:+0.070

Cartesian Therapeutics Inc (RNAC) is a clinical-stage biotechnology company focused on cell therapy for autoimmune diseases, with its lead asset, Descartes-08, entering Phase 3 trials. The stock is currently rated a "Buy" by analysts with a target price of $33.83, indicating significant upside potential. …

Carter’s (NYSE:CRI) Q2 CY2026 Sales Top Estimates But Quarterly Revenue Guidance Misses Expectations

Carter's (NYSE:CRI) Q2 CY2026 Sales Top Estimates But Quarterly Revenue Guidance Misses Expectations Children's apparel manufacturer Carter's (NYSE:CRI) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 5.2% year on year to $615.5 million. On the other hand, next quarter's revenue guidance …

Carter Bankshares director Robert Bolton sells $51,900 in shares

Carter Bankshares director Robert Bolton sold 1,500 shares of company stock for $51,900, with the stock trading near its 52-week high after a significant return over the past year. Bolton still directly and indirectly holds a substantial number of shares. This transaction follows other …

Carter Bankshares (CARE) director sells 1,500 shares of common stock

Carter Bankshares director Robert M. Bolton indirectly sold 1,500 shares of Common Stock at $34.60 per share on July 30, 2026, through Iron Bay Fund (Limited Partner). Following this transaction, Bolton holds 55,000 indirectly held shares and 12,629 directly held shares. The sale was …

Carter Bankshares president Langs sells $86,339 in company stock

Bradford N. Langs, President and Chief Strategy Officer of Carter Bankshares, Inc. (NASDAQ:CARE), sold 2,500 shares of company stock on July 30, 2026, for a total of $86,339. This sale occurred while the stock was trading near its 52-week high, following a significant 99% …

Cartesian Therapeutics Inc (RNAC) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Cartesian Therapeutics Inc (RNAC), noting its current valuation score is 6.20, ranking it 328 out of 385 in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -1.35 and mentions that relevant …

How Carter’s Traffic-Led Growth And EPS Pressure At Carter's (CRI) Has Changed Its Investment Story

Carter's (CRI) is facing a mix of revenue growth driven by increased retail traffic and new collaborations, alongside pressure on earnings per share due to tariffs and inflation. The company's strategy focuses on direct-to-consumer sales and pricing initiatives, reinforcing its existing investment narrative where …

Carter's, Inc. (NYSE:CRI) Receives Average Recommendation of "Hold" from Brokerages

Carter's, Inc. (NYSE:CRI) has received a consensus "Hold" rating from nine brokerages, with an average 12-month price target of $41.17, slightly above its current trading price of $37.82. The company recently exceeded quarterly earnings expectations with an adjusted EPS of $0.39 and revenue of …

Carter's Earnings: What To Look For From CRI

Carter's (NYSE:CRI), a children's apparel manufacturer, is set to report earnings this Friday. Last quarter, the company surpassed revenue expectations and saw strong EPS performance. Investors will be watching revenue growth, which is anticipated to be around 3.5% year-on-year, and analyst reconfirmations of estimates.

The Manufacturers Life Insurance Company Buys 643,071 Shares of The Descartes Systems Group Inc. $DSGX

The Manufacturers Life Insurance Company has significantly increased its stake in The Descartes Systems Group Inc., purchasing an additional 643,071 shares to own a total of 1.10 million shares valued at approximately $78.8 million. Other institutional investors like Vanguard Group Inc. and Mackenzie Financial …